Cynthia Butitta - Kite Pharma CFO and COO

COO

Ms. Cynthia M. Butitta is Chief Operating Officer of the Company. She was Senior Vice President and Chief Financial Officer at NextWave Pharmaceuticals, Inc., a specialty pharmaceutical company. Prior to that, Ms. Butitta served as Chief Operating Officer of Telik, Inc., a biopharmaceutical company, from March 2001 to December 2010 and as its Chief Financial Officer from August 1998 to December 2010. Ms. Butitta also served as Principal Accounting Officer of Telik, Inc. until December 2010. She served as a Director of Catalyst Semiconductor Inc., a semiconductor products company, from June 2000 to February 2003 since 2016.
Age 61
Tenure 8 years
Professional MarksMBA
Phone310 824-9999
Webwww.kitepharma.com
Butitta received her B.S. degree with honors in Business and Accounting from Edgewood College in Madison, Wisconsin, and an M.B.A. degree in Finance from the University of Wisconsin, Madison.

Kite Pharma Management Efficiency

Kite Pharma's management efficiency ratios could be used to measure how well Kite Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 2 records

COO Age

James JDMorgan Stanley
63
James RosenthalMorgan Stanley
61
Kite Pharma, Inc., a clinicalstage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. Kite Pharma (KITE) is traded on NASDAQ Exchange in USA and employs 184 people.

Management Performance

Kite Pharma Leadership Team

Elected by the shareholders, the Kite Pharma's board of directors comprises two types of representatives: Kite Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kite. The board's role is to monitor Kite Pharma's management team and ensure that shareholders' interests are well served. Kite Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kite Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ran Nussbaum, Independent Director
Jonathan Peacock, Independent Director
Shawn Tomasello, Chief Commercial Officer
Jian Irish, Senior Vice President - Supply Chain
Cynthia Butitta, CFO and COO
Franz Humer, Director
Timothy Moore, Executive Vice President - Technical Operations
Jeffrey Wiezorek, Vice President - Clinical Development
Ian Clark, Independent Director
Steven Ruchefsky, Independent Director
Joshua Kazam, Director
Helen Kim, Executive Vice President - Business Development
Helen MBA, Executive VP of Bus. Devel.
David Bonderman, Lead Independent Director
David Chang, Executive Vice President - Research and Development, Chief Medical Officer
Arie Belldegrun, Executive Chairman of the Board and Presidentident, CEO, Founder
Christine Cassiano, Senior Vice President - Corporate Communications and Investor Relations
Owen Witte, Director
Paul Jenkinson, CFO
Marc Better, VP of Translation Medicine
Farah Champsi, Independent Director
Roy Doumani, Independent Director
Rizwana Sproule, Vice President - Regulatory Affairs
Margo Roberts, Chief Scientific Officer

Kite Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kite Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kite Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kite Pharma's short interest history, or implied volatility extrapolated from Kite Pharma options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Kite Stock

If you are still planning to invest in Kite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kite Pharma's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios